Your search returned 3 results.

Results
	1.	After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. [Review] MedStar authors: Sugarbaker, Paul H PMID: 35398760 Year: 2022 Citation: Surgical Oncology. 42:101757, 2022 Jun. Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Sugarbaker PH DOI: https://dx.doi.org/10.1016/j.suronc.2022.101757 Add to cart (remove)
	2.	Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial. MedStar authors: Sugarbaker, Paul H PMID: 30838646 Year: 2019 Citation: Journal of Surgical Oncology. 119(7):999-1010, 2019 Jun. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Carleer R, Geboers K, Lemoine L, Sugarbaker P, Thijssen E, van der Speeten K DOI: https://dx.doi.org/10.1002/jso.25437 Add to cart (remove)
	3.	Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. [Review] MedStar authors: Sugarbaker, Paul H PMID: 33004272 Year: 2021 Citation: European Journal of Surgical Oncology. 47(4):738-742, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Evans S, Nagourney AJ, Nagourney RA, Sugarbaker PH, Tran PH DOI: https://dx.doi.org/10.1016/j.ejso.2020.09.017 Add to cart (remove)

Powered by Koha